Company · CIK 0001817713 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Janux Therapeutics, Inc. · JANX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 GForm 4 → | Jul 31, 8:00 pm EDT | David Alan CampbellPresident and CEO, Director | 123,840 | — | — | 264,742 | — | |
| Jul 8, 2026 MForm 4 → | Jul 10, 8:00 pm EDT | David Alan CampbellPresident and CEO, Director | 7,000 | $4.21 | $29,470 | 388,582 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2026 MForm 4 → | Jul 10, 8:00 pm EDT | David Alan CampbellPresident and CEO, Director | 7,000 | — | — | 697,550 | — |